Order Article Reprints

Gilhodes J, Meola A, Cabarrou B, Peyraga G, Dehais C, Figarella-Branger D, Ducray F, Maurage C-A, Loussouarn D, Uro-Coste E, et al. A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas. Cancers. 2023; 15(12):3067. https://doi.org/10.3390/cancers15123067

Gilhodes, Julia, Adèle Meola, Bastien Cabarrou, Guillaume Peyraga, Caroline Dehais, Dominique Figarella-Branger, François Ducray, Claude-Alain Maurage, Delphine Loussouarn, Emmanuelle Uro-Coste, and et al. 2023. "A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas" Cancers 15, no. 12: 3067. https://doi.org/10.3390/cancers15123067

Gilhodes, J., Meola, A., Cabarrou, B., Peyraga, G., Dehais, C., Figarella-Branger, D., Ducray, F., Maurage, C.-A., Loussouarn, D., Uro-Coste, E., Cohen-Jonathan Moyal, E., & POLA Network. (2023). A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas. Cancers, 15(12), 3067. https://doi.org/10.3390/cancers15123067